PFA hosts British South Asian footballer event in London
By Sarwar AlamJun 08, 2021
IN a first-of-its-kind player event as part of the PFA's Asian Inclusion Mentoring Scheme (AIMS) - some of the best footballing talents from across the South Asian community gathered at the Bridgestone Arena near Wembley Stadium.
The event was attended by more than 20 players including AEK Larnaca full-back Simran Singh Thandi and Manchester United's Zidane Iqbal.
Then there was Dinesh Gillela, who captained Bournemouth's U21s to two trophy wins last season - joined scholars Sonny Singh (Sunderland) and Yasin Arai (Stevenage), and around 15 youngsters enrolled at academies across the divisions at the event.
The PFA scheme aims to enhance the experience of South Asian footballers at all levels of the professional game by creating a structured network of support that allows them to thrive.
Danny Batth, Neil Taylor, Otis Khan and Zesh Rehman are among the senior footballers mentoring scholars and emerging pros. They also share their academy experiences with the youngsters.
Thandi, who spent 10 years in Leicester's youth ranks before going on to turn pro at Stoke in 2018, said he hoped the experience would benefit talented South Asian youngsters, who are already training in academies.
"I am so proud to see all of this," the 21-year-old right-back told Sky Sports News.
"I think it's a great experience for the kids to see players of different age groups at different clubs, it's amazing to get them all in one place."
Defender Gillela, 21, told Sky Sports News: "I love doing things like this, giving back and helping and sharing my knowledge where I can. If I was in their shoes I would love to have spoken to someone in my current position.
"It's like gold dust, even for me, speaking to the likes of Danny Batth, Mal Benning, Neil Taylor - these are big names in the football league, the football community and the football world.
"For me, learning off them, is (exactly) how I think about trying to give back to the younger ones coming through now."
Towards the end of last season, the number of contracted British South Asian league footballers were at 16, with a few out of contract and looking to finalise moves to other clubs.
While answering questions from South Asian academy players aged between eight and 15, Sonny Singh said: "I know how ruthless football can be because I was released at a young age, at the age of 10, and you think the world is going to end - (at that age) you're thinking you'd be at the club forever. It's just about how you bounce back. The lows are what make you come back stronger and those setbacks help you learn more about the game.
"You know not it's not going to be an easy road, you know you are going to have to work hard, but you're (likely) going to have the support from your family - I have great parents who have supported me through my lows.
"When you're up it's amazing, you feel like you are on top of the world, but the main thing is enjoying it and being happy with what you are doing."
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.